Depression And Alzheimer's Treatments At A Crossroads

Depression And Alzheimer's Treatments At A Crossroads

  • Af
  • Episode
      781
  • Published
      10. nov. 2022
  • Forlag
0 Anmeldelser
0
Episode
781 of 1419
Længde
11M
Sprog
Engelsk
Format
Kategori
Fakta

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem. As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Depression And Alzheimer's Treatments At A Crossroads

Other podcasts you might like ...